Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Valens Company Inc - SIC # 2833 - MEDICINAL CHEMICALS AND BOTANICAL PRODUCTS
Ticker
Exchange
SIC #
Website
Latest Ticker
VLNS
New York
2833
https://thevalenscompany.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Valens Company Inc
The Valens Company Signs Exclusive Cannabis Partnership with Coldhaus Distribution
- Jun 22nd, 2022 11:00 am
The Valens Company Receives Additional Product Listings with SQDC & Introduces Bon Jak an Exclusive Cannabis Brand in Quebec
- Jun 16th, 2022 11:00 am
The Valens Company Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
- Jun 15th, 2022 10:00 pm
Cannabis Industry Investor Conference Presentations Now Available for On-Demand Viewing
- Jun 8th, 2022 12:35 pm
Cannabis Industry Investor Conference: Company Executives Present June 7th
- Jun 3rd, 2022 12:35 pm
The Valens Company to Participate in Upcoming June Investor Conferences
- Jun 2nd, 2022 11:00 am
The Valens Company Continues to Expand Canadian Recreational Market Share in April
- May 25th, 2022 11:00 am
The Valens Company Appoints New Board Chair and Provides an Update on its Annual General Meeting of Shareholders
- May 16th, 2022 9:00 pm
The Valens Company to Participate in Upcoming Investor Conferences
- May 4th, 2022 9:00 pm
The Valens Company to Participate in AGP Spring Consumer Cannabis Conference
- Apr 27th, 2022 9:00 pm
The Valens Company Secures Agreement for Green Roads Kiosks in Major Malls Across the United States
- Apr 21st, 2022 11:00 am
The Valens Company Reports First Quarter Fiscal 2022 Financial Results
- Apr 13th, 2022 9:00 pm
The Valens Company to Hold Conference Call to Discuss Financial Results for the First Quarter of 2022
- Apr 7th, 2022 9:00 pm
The Valens Company Issues Letter to Shareholders & Announces Initiation of Second Wave of Integration Initiatives to Increase Efficiencies and Drive Additional Cost Savings
- Apr 5th, 2022 9:00 pm
The Valens Company Closes Previously Announced Bought Deal Financing Including Exercise of Over-Allotment Option
- Apr 5th, 2022 1:05 pm
IIROC Trade Resumption - VLNS
- Mar 30th, 2022 12:02 pm
The Valens Company Announces Approximately USD$22.5 Million Bought Deal Offering of Units
- Mar 29th, 2022 9:23 pm
IIROC Trading Halt - VLNS
- Mar 29th, 2022 8:12 pm
The Valens Company Continues to Grow National Market Share
- Mar 16th, 2022 9:00 pm
Green Roads Announces Support for the Arthritis Foundation and Launch of an Arthritis Pain Relief Roll-On
- Mar 8th, 2022 2:00 pm
Scroll